Smartphone technology for fostering goal-directed ambulation and object use in people with moderate Alzheimer’s disease

References

• Ambrose CT. Neuroangiogenesis: a vascular basis for Alzheimer’s disease and cognitive decline during aging. JAD. 2012;32(3):773–788.
   Google Scholar
• Bernick C, Cummings J, Raman R, et al. Age and rate of cognitive decline in Alzheimer disease: implications for clinical trials. Arch Neurol. 2012;69(7):901–905.
   Google Scholar
• Brayne C, Miller B. Dementia and aging populations: a global priority for contextualized research and health policy. PLoS Med. 2017;14(3):e1002275. doi.org/10.1371/journal.pmed.1002275
   Google Scholar
• Prince M, Comas-Herrera A, Knapp M, et al. World Alzheimer report 2016: improving healthcare for people living with dementia. London (UK): Alzheimer’s Disease International (ADI); 2016.
   Google Scholar
• Wu Y-T, Fratiglioni L, Matthews FE, et al. Dementia in western Europe: epidemiological evidence and implications for policy making. Lancet Neurol. 2016;15(1):116–124.
   Google Scholar
• Cummings J, Blennow K, Johnson K, et al. Anti-Tau trials for Alzheimer’s disease: a report from the EU/US/CTAD task force. J Prev Alzheimers Dis. 2019;6(3):157–163.
   Google Scholar
• Deshpande P, Gogia N, Singh A. Exploring the efficacy of natural products in alleviating Alzheimer’s disease. Neural Regen Res. 2019;14(8):1321–1329.
   Google Scholar
• Khazdair MR, Anaeigoudari A, Hashemzehi M, et al. Neuroprotective potency of some spice herbs, a literature review. J Tradit Complement Med. 2018;30(9):98–105.
   Google Scholar
• Mitra S, Behbahani H, Eriksdotter M. Innovative therapy for Alzheimer’s disease-with focus on biodelivery of NGF. Front Neurosci. 2019;13:38.
   Google Scholar
• Tosi G, Pederzoli F, Belletti D, et al. Nanomedicine in Alzheimer’s disease: amyloid beta targeting strategy. Prog Brain Res. 2019;245:57–88.
   Google Scholar
• Perri R, Monaco M, Fadda L, et al. Neuropsychological correlates of behavioral symptoms in Alzheimer’s disease, frontal variant of frontotemporal, subcortical vascular, and lewy body dementias: a comparative study. J Alzheimers Dis. 2014;39(3):669–677.
   Google Scholar
• Salehpoor F, Hamblin MR, DiDuro JO. Rapid reversal of cognitive decline, olfactory dysfunction, and quality of life using multi-modality photobiomodulation therapy: case study. Photobiomodul PhotomedLaser Surg. 2019;37(3):159–167.
   Google Scholar
• Sikkes SA, Pijnenburg YA, Knol DL, et al. Assessment of instrumental activities of daily living in dementia: diagnostic value of the Amsterdam Instrumental Activities of Daily Living Questionnaire. J Geriatr Psychiatry Neurol. 2013;26(4):244–250.
   Google Scholar
• Soto ME, Secher M, Gillette-Guyonnet S, et al. Weight loss and rapid cognitive decline in community-dwelling patients with Alzheimer’s disease. J Alzheimers Dis. 2012; 28(3):647–654.
   Google Scholar
• Wilson RS, Segawa E, Boyle PA, et al. The natural history of cognitive decline in Alzheimer’s disease. Psychol Aging. 2012;27(4):1008–1017.
   Google Scholar
• Bazzari FH, Abdallah DM, El-Abhar HS. Pharmacological interventions to attenuate Alzheimer’s disease progression: the story so far. Curr Alzheimer Res. 2019;16(3):261–277.
   Google Scholar
• Berk C, Paul G, Sabbagh M. Investigational drugs in Alzheimer’s disease: current progress. Expert Opin Investig Drugs. 2014;23(6):837–846.
   Google Scholar
• Gauthier S, Albert M, Fox N, et al. Why has therapy development for dementia failed in the last two decades? Alzheimers Dement. 2016;12(1):60–64.
   Google Scholar
• Kurz A, Grimmer T. Efficay of memantine hydrochloride once-daily in Alzheimer’s disease. Expert Opin Pharmacother. 2014;15(13):1955–1960.
   Google Scholar
• Liang J, Li J, Jia R, et al. Identification of the optimal cognitive drugs among Alzheimer’s disease: a Bayesian meta-analytic review. Clin Interv Aging. 2018;13:2061–2073.
   Google Scholar
• Campos C, Rocha NB, Vieira RT, et al. Treatment of cognitive deficits in Alzheimer’s disease: a psychopharmacological review. Psychiatr Danub. 2016;28(1):2–12.
   Google Scholar
• Owen RT. Memantine and donepezil: a fixed drug combination for the treatment of moderate to severe Alzheimer’s dementia. Drugs Today (Barc.). 2016;52(4):239–248.
   Google Scholar
• Wesson Ashford J. Treatment of Alzheimer’s disease: the legacy of the cholinergic hypothesis, neuroplasticity, and future directions. J Alzheimers Dis. 2015;47(1):149–156.
   Google Scholar
• Ben-Sadoun G, Sacco G, Manera V, et al. Physical and cognitive stimulation using an exergame in subjects with normal aging, mild and moderate cognitive impairment. J Alzheimers Dis. 2016;53(4):1299–1314.
   Google Scholar
• Boyd HC, Evans NM, Orpwood RD, et al. Using simple technology to prompt multistep tasks in the home for people with dementia: an exploratory study comparing prompting formats. Dementia (London). 2017;16(4):424–442.
   Google Scholar
• Lancioni GE, O’Reilly MF, Sigafoos J, et al. Persons with mild and moderate Alzheimer’s disease use simple technology to support their leisure engagement. Adv Neurodev Disord. 2017;1(1):31–36.
   Google Scholar
• Lancioni GE, Singh NN, O’Reilly MF, et al. Technology-based behavioral interventions for daily activities and supported ambulation in people with Alzheimer’s disease. Am J Alzheimers Dis Other Demen. 2018;33(5):318–326.
   Google Scholar
• Leuty V, Boger J, Young L, et al. Engaging older adults with dementia in creative occupations using artificially intelligent assistive technology. Assist Technol. 2013;25(2):72–79.
   Google Scholar
• Braley R, Fritz R, Van Son CR, et al. Prompting technology and persons with dementia: the significance of context and communication. Gerontologist. 2019;59(1):101–111.
   Google Scholar
• Czarnuch S, Ricciardelli R, Mihailidis A. Predicting the role of assistive technologies in the lives of people with dementia using objective care recipient factors. BMC Geriatr. 2016;16(1):143. DOI:10.1186/s12877-016-0314-2
   Google Scholar
• Ienca M, Jotterand F, Elger B, et al. Intelligent assistive technology for Alzheimer’s disease and other dementias: a systematic review. J Alzheimers Dis. 2017;56(4):1301–1340.
   Google Scholar
• Jiancaro T, Jaglal SB, Mihailidis A. Technology, design and dementia: an exploratory survey of developers. Disabil Rehabil Assist Technol. 2017;12(6):573–584.
   Google Scholar
• Robilard JM, Cleland I, Hoey J, et al. Ethical adoption: a new imperative in the development of technology for dementia. Alzheimers Dement. 2018;14(9):1104–1113.
   Google Scholar
• Goh AMY, Loi SM, Westphal A, et al. Person-centered care and engagement via technology of residents with dementia in aged care facilities. Int Psychogeriatr. 2017;29(12):2099–2103.
   Google Scholar
• Joddrell P, Astell AJ. Studies involving people with dementia and touchscreen technology: a literature review. JMIR Rehabil Assist Technol. 2016;3(2):e10. DOI:10.2196/rehab.5788
   Google Scholar
• Riley P, Alm N, Newell A. An interactive tool to promote musical creativity in people with dementia. Comput Human Behav. 2009;25(3):599–608.
   Google Scholar
• Tyack C, Camic PM. Touchscreen interventions and the well-being of people with dementia and caregivers: a systematic review. Int Psychogeriatr.. 2017;29(8):1261–1280.
   Google Scholar
• Wang RH, Sudhama A, Begum M, et al. Robots to assist daily activities: views of older adults with Alzheimer’s disease and their caregivers. Int Psychogeriatr. 2017;29(1):67–79.
   Google Scholar
• Lancioni GE, Singh NN, O’Reilly MF, et al. Promoting supported ambulation in persons with advanced Alzheimer’s disease: a pilot study. Disabil Rehabil Assist Technol. 2018;13(1):101–106.
   Google Scholar
• Etikan I, Musa SA, Alkassim RS. Comparison of convenience sampling and purposive sampling. Am J Theoretical and Applied Statistics. 2016;5(1):1–4.
   Google Scholar
• Folstein M, Folstein SE, McHugh PR. “Mini-Mental State” a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189–198.
   Google Scholar
• Desmond D, Layton N, Bentley J, et al. Assistive technology and people: a position paper from the first global research, innovation and education on assistive technology (GREAT) summit. Disabil Rehabil Assist Technol. 2018;13(5):437–444.
   Google Scholar
• Scherer MJ, MacLachlan M, Khasnabis C. Introduction to the special issue on the first global research, innovation, and education on assistive technology (GREAT) summit and invitation to contribute to and continue the discussions. Disabil Rehabil Assist Technol. 2018;13(5):435–436.
   Google Scholar
• Staal J, Pinkney L, Roane DM. Assessment of stimulus preferences in multisensory environment therapy for older people with dementia. Br J Occup Ther. 2003;66(12):542–550.
   Google Scholar
• Kazdin AE. Behavior modification in applied settings. 7th ed. New York (NY): Waveland; 2012.
   Google Scholar
• Barlow DH, Nock M, Hersen M. Single-case experimental designs: strategies for studying behavior change. 3rd ed. New York (NY): Allyn & Bacon; 2009.
   Google Scholar
• Siegel S, Castellan NJ. Nonparametric statistics for the behavioral sciences. 2nd ed. New York (NY): McGraw-Hill; 1988.
   Google Scholar
• Brett L, Traynor V, Stapley P. Effects of physical exercise on health and well-being of individuals living with a dementia in nursing homes: a systematic review. J Am Med Dir Assoc. 2016;17(2):104–116.
   Google Scholar
• Lancioni G, Singh N, O’Reilly M, et al. A technology-aided program for helping persons with Alzheimer’s disease perform daily activities. J Enabling Technol. 2017;11(3):85–91.
   Google Scholar
• McCarthy I, Suzuki T, Holloway C, et al. Detection and localization of hesitant steps in people with Alzheimer’s disease navigating routes of various complexity. Healthc Technol Lett. 2019;6(2):42–47.
   Google Scholar
• Smit D, de Lange J, Willemse B, et al. Activity involvement and quality of life of people at different stages of dementia in long term care facilities. Aging Ment Health. 2016;20(1):100–109.
   Google Scholar
• Toots A, Littbrand H, Holmberg H, et al. Walking aids moderate exercise effects on gait speed in people with dementia: a randomized controlled trial. J Am Med Dir Assoc. 2017;18(3):227–233.
   Google Scholar
• Wajda DA, Mirelman A, Hausdorff JM, et al. Intervention modalities for targeting cognitive-motor interference in individuals with neurodegenerative disease: a systematic review. Expert Rev Neurother. 2017;17(3):251–261.
   Google Scholar
• Scherer MJ, Craddock G, Mackeogh T. The relationship of personal factors and subjective well-being to the use of assistive technology devices. Disabil Rehabil. 2011;33(10):811–817.
   Google Scholar
• Pierce WD, Cheney CD. Behavior analysis and learning. 4th ed. New York (NY): Psychology Press; 2008.
   Google Scholar
• Moore K, Delaney JA, Dixon MR. Using indices of happiness to examine the influence of environmental enhancements for nursing home residents with Alzheimer’s disease. J Appl Behav Anal. 2007;40(3):541–544.
   Google Scholar
• Smith RO, Scherer MJ, Cooper R, et al. Assistive technology products: a position paper from the first global research, innovation, and education on assistive technology (GREAT) summit. Disabil Rehabil Assist Technol. 2018;13(5):473–485.
   Google Scholar
• Kazdin AE. Single-case research designs: Methods for clinical and applied settings. 2nd ed. New York (NY): Oxford University Press; 2011.
   Google Scholar
• Luiselli JK, Bass JD, Whitcomb SA. Teaching applied behavior analysis knowledge competencies to direct-care service providers: outcome assessment and social validation of a training program. Behav Modif. 2010;34(5):403–414.
   Google Scholar
• Mendonca GV, Pezarat-Correia P, Vaz JR, et al. Impact of exercise training on physiological measures of physical fitness in the elderly. Curr Aging Sci.. 2016;9(4):240–259.
   Google Scholar